Daily Walks Near Traffic Pollution Increased COPD Cough, Sputum
Traffic-related air pollution can worsen respiratory symptoms during daily exercise for people with chronic lung disease.
Tag: COPD
All
Latest
Daily Walks Near Traffic Pollution Increased COPD Cough, Sputum
Traffic-related air pollution can worsen respiratory symptoms during daily exercise for people with chronic lung disease.
Read More
Voice Changes May Help Monitor Asthma and COPD at Home
New research suggests acoustic speech features can identify respiratory exacerbations from the first day of onset.
Read More
Lung Denervation Trial to Target COPD Phenotype
Nuvaira treated the first patient treated in a clinical trial evaluating a one-time lung denervation therapy for patients with specific COPD symptoms.
Read More
American Lung Association Launches COPD Management Program
American Lung Association is launching a new initiative to help the more than 16 million people in the US living with COPD manage symptoms and improve quality of life.
Read More
Alpha-1 Antitrypsin Deficiency Drug Enters Ph3 Trial
Grifols enrolled the first patient in its Phase 3 SWIFT-SC clinical trial to evaluate its subcutaneous Alpha1-Proteinase Inhibitor for the treatment of alpha1-antitrypsin (AAT) deficiency.
Read More
COPD Patients Need More Education on Wildfire Smoke Risks
New research suggests COPD patients lack critical information and clinical guidance to manage respiratory risks during wildfire events.
Read More
ENA Respiratory Secures Two US Patents for COPD Therapy
ENA Respiratory received notices of allowance for two US patents covering its innate immune modulators and their application in preventing COPD exacerbations.
Read More
Inhaled Vitamin D for COPD, Asthma
Researchers suggest delivering vitamin D directly to the lungs could bypass the limitations of oral supplements in treating COPD and asthma.
Read More
Nebulized Dual Bronchodilator Aero-007 Improved COPD Lung Function
AERO-007 demonstrated significant lung function improvements over 24 hours in patients with moderate-to-severe COPD.
Read More
Worse COPD, Pneumonia Outcomes at Private Equity Hospitals
Patients with pneumonia or COPD faced higher mortality risks and readmission at facilities owned by private equity firms, according to new research.
Read More
Alpha-1 Drug Candidate Superior to Standard Care
Phase 2 data for efdoralprin alfa demonstrate the recombinant protein maintains normal protein levels with less frequent dosing than current standards of care for patients with alpha-1 antitrypsin deficiency (AATD)-related emphysema.
Read More
Viz.ai Launches Ai-powered Viz Pulmonary Suite
The new suite integrates workflows for COPD, lung nodules, and pulmonary embolism to improve patient follow-up and treatment times.
Read More
Why Some Alpha-1 Patients Develop Liver Disease
A newly discovered biological process protects liver cells from protein buildup in patients with alpha-1-antitrypsin deficiency.
Read More
ALA Launches Study to Test Omalizumab for COPD Flare-ups
The COPD-OMA trial will examine if the asthma drug omalizumab (Xolair) benefits COPD patients with sensitivities to indoor allergens.
Read More
WHO Expands Asthma Care in Nepal, Sri Lanka
The initiative focuses on integrating respiratory services into primary healthcare to improve diagnosis and treatment access.
Read More
Tozorakimab Reduces COPD Flare-Ups in Ph3 Trial
The MIRANDA study found tozorakimab significantly lowered the rate of moderate-to-severe respiratory worsening in patients regardless of smoking history or specific white blood cell counts.
Read More
Soy, Legumes May Improve COPD Symptoms
New research suggests isoflavones found in plant-based foods like soy and legumes can reduce inflammation and coughing for patients with COPD.
Read More
Phone-based Training Improves COPD Inhaler Use
A study of Medicare Advantage beneficiaries with COPD shows that pharmacist-led telephone education significantly reduces errors in medication delivery.
Read More
Ai Tool Linked to Higher Flu Vaccine Rates, Fewer Hospitalizations for COPD Patients
A new whitepaper shows that real-time clinical insights for primary care physicians led to higher flu vaccination rates and fewer emergency visits for high-risk populations, including COPD patients.
Read More
Rademikibart Tied to Rapid Lung Function Improvement in Asthma, COPD
Phase 1 study revealed significant FEV1 improvements within 15 min of a single dose of IV rademikibart — an antibody targeting interleukin-4 receptor alpha.
Read More
Tozorakimab Reduced COPD Exacerbations in Ph3 Trials
The monoclonal antibody Tozorakimab showed significant clinical benefit in reducing COPD flare-ups for a broad range of patients, including former and current smokers.
Read More
Wearable Sleep Data Predicts Patient Engagement in Remote COPD Rehab
Sleep metrics from wrist monitors can identify which COPD patients may need more support during pulmonary rehab.
Read More
COPD Breathlessness Action Plans May Reduce Emergency Care
Non-pharmacological strategies like breathing techniques and positioning help COPD patients manage acute episodes and improve confidence.
Read More
COPD Patients Commonly Misuse Medications
Affordability and education are preventing COPD patients from remaining adherent to their prescribed pharmacologies.
Read More